HOME PAGE
>
Services
>
Solvay Pharmaceuticals Inc. a été informée du dépôt d’une demande d’enregistrement d’un générique d’Androgel® aux USA
Other Solvay Sites
------------------------------------------------
Solvay.com
---------- Business Portals ----------
Chemicals Portal
Plastics Portal
> Other sites by Businesses
----------- Country Portals -----------
Solvay Austria
Solvay Asia Pacific
Solvay China
Solvay Deutschland
Solvay France
Solvay Iberica
Solvay Italia
Solvay Nordic
Solvay North America
Solvay Portugal
Solvay Schweiz
> Other sites by Regions
Ce Site
Tous
HOME PAGE
About us
History
Ernest Solvay
Products evolution
Timeline
Management
Locations
Strategy
Mission, Vision and Values
The Solvay Code of Conduct
Government & Public Affairs
Sectors approach
Solar Impulse
People
Recruitment
Your career
Key figures
Sectors & Markets
Plastics Sector
Automobile industry
Chemical industry
Construction and architecture
Consumer goods
Electricity and electronics
Human health
Packaging
Water and environment
Other industries
Pharmaceuticals Sector
Chemicals Sector
Glass industry
Chemical industry
Detergents, cleaning and hygiene products
Paper
Construction and architecture
Human health
Water and environment
Automobile industry
Human and animal food processing
Electricity and Electronics
Consumer goods
Other industries
e-Business
Products
Innovation
Innovation and Strategy
New Business Development
Sustainable Energies
Organic Electronics
Corporate Venturing
Opportunities
Milestones
Nanotechnologies
Applied Innovation
Solvay Innovation Trophy
Sustainable development
Sustainability Commitment
Strategic framework
Corporate Social Responsibility
REACH regulation
Press office
Investor relations
Contacts
Mailing list
Library
Annual Reports
Sustainable Development Reports
Image gallery
Products
People
Plants
Research
Solar Impulse
Airplane
People
Technical aspects
All Solvay websites
Worldwide presence
Glossary
News
version:
[EN]
-
[NL]
-
> 10 juin, 2009<
Solvay Pharmaceuticals Inc. a été informée du dépôt d’une demande d’enregistrement d’un générique d’Androgel® aux USA
Embargo : le 10 juin 2009 à 17.40 heures (heure de Bruxelles)
|
Envoyer par email
|
© Solvay S.A • Informations importantes :
Privacy Policy
-
Disclaimer
• Pour tout commentaire, veuillez contacter le
webmaster
Date de dernière mise à jour: 12/3/2010
